Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
172.50    -2.50 (-1.43%)
Bid:
170.00
Ask:
175.00
Spread: 5.00 (2.941%)
Market Cap: £3.20m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

H1 2025 Trading Update

10 Jul 2025 07:00

RNS Number : 4457Q
Norman Broadbent PLC
10 July 2025
 

10 July 2025

 

Norman Broadbent plc

("Norman Broadbent" or the "Company")

 

 

H1 2025 TRADING UPDATE

 

Record first half performance

 

Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, is pleased to announce the following unaudited trading update for the six months ended 30 June 2025 ("H1 2025").

 

Financial highlights

 

·

Record first half performance with net fee income ("NFI") of £6.0m up 33% (2024: £4.5m)

o

Executive Search NFI up 36% on H1 2024

o

Interim Management up 21% on H1 2024

·

Q2 2025 NFI of £3.0m up 30% (2024: £2.3m), maintaining the exceptional momentum from the previous two quarters 

·

Underlying EBITDA1 expected to be in the range of £0.75m to £0.8m (2024: £0.1m)

·

Net cash(2) of £0.2m as at 30 June 2025 (30 June 2024: net debt(2) of £0.7m). This is after annual bonus payments, historical rates refund (£0.1m) and full repayment of the CBILs loan

·

Number of search mandates secured up 37% on H1 2024, and average fee value per mandate increased by 36%

·

Careful management of cost base continues, with London office move saving c£0.1m year-on-year and improved processes and support technologies continuing to drive efficiencies

 

[1] Underlying EBITDA excludes share based payment charges

[2]Excluding lease liabilities

 

 

Kevin Davidson, CEO of Norman Broadbent, commented:

 

"I am delighted to be announcing this record-breaking trading update for H1 2025, particularly in the face of a persistently challenging market. It speaks to the success of the work undergone to transform the Company in recent years to become the ambitious, agile and resilient organisation it is today.

 

Our values-based and award-winning culture will always be the foundation of our growth engine. With that in mind, we have continued to invest in enhancing productivity and value-adding technologies and the development of our people. This, of course, will continue to be undertaken within the parameters of our prudent focus on overhead management and cash generation.

 

I remain optimistic about the Company's prospects, particularly noting the increased value of contracted revenue going into Q3 2025, and with our consistent focus on delivering sustainable and profitable growth over the long term."

 

Contacts: 

 

Norman Broadbent plc 

+44 (0)20 7484 0000

Kevin Davidson, CEO 

Mehr Malik, CFO

 

Shore Capital (Nominated Adviser and Broker)  

 

+44 (0)20 7408 4090

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

 

Alma (Financial Communications Adviser)

   +44 (0)20 3405 0205

Rebecca Sanders-Hewett

normanbroadbent@almastrategic.com

Kinvara Verdon

David Ison

  

About Norman Broadbent:

 

Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally.  

Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.

 

www.normanbroadbent.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKCBKFBKDAOK
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.